Literature DB >> 17593088

Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002.

Ken Marumo1, Hiroomi Kanayama, Noriomi Miyao, Hayakazu Nakazawa, Seiichiro Ozono, Shigeo Horie, Satoshi Nagamori, Tatsuo Igarashi, Michihiko Hasegawa, Go Kimura, Masahiro Nakao, Takahisa Nakamoto, Seiji Naito.   

Abstract

OBJECTIVE: To investigate the incidence of renal cell carcinoma, classified by sex, age group and region in Japan, following a 5-year interval after a previous survey performed in 1997.
METHODS: The survey was conducted between the beginning of January 2002 and the end of December 2002. A total of 1288 institutions in all 47 prefectures throughout Japan were requested to register cases.
RESULTS: There were 7405 persons with renal cell carcinoma, consisting of 5063 males and 2342 females. Crude incidence rates were 8.2 and 3.6 per 100 000 population for men and women, respectively. Incidence rates in the Hokkaido region were highest followed by the Shikoku region.
CONCLUSIONS: Despite incidence of renal cell carcinoma increasing to 7405 from the 6358 persons in 1997, statistical data reported by the Ministry of Health, Labor and Welfare indicate that rising age-adjusted death rate for this tumor reached a ceiling in the past decade. Early detection may have contributed to this current trend; however, further epidemiological research is required to fully elucidate this.

Entities:  

Mesh:

Year:  2007        PMID: 17593088     DOI: 10.1111/j.1442-2042.2007.01739.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  13 in total

1.  Histology is a Prognostic Indicator After Pulmonary Metastasectomy from Renal Cell Carcinoma.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Keiju Aokage; Masayuki Nakao; Junji Yoshida; Mitsuhiro Kamiyoshihara; Masayuki Sugano; Yusuke Takahashi; Seshiru Nakazawa; Toshiteru Nagashima; Kai Obayashi; Tomoyuki Hishida; Masahiro Tsuboi; Shohei Mori; Mingyon Mun; Sakae Okumura; Hitoshi Igai; Noriyuki Matsutani; Akira Mogi; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

Review 2.  Epidemiology of renal cancer in developing countries: Review of the literature.

Authors:  Mauricio Medina-Rico; Hugo López Ramos; Manuel Lobo; Jorge Romo; Juan Guillermo Prada
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

3.  Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.

Authors:  Noriyuki Ito; Shinsuke Kojima; Satoshi Teramukai; Yoshiki Mikami; Osamu Ogawa; Tomomi Kamba
Journal:  Int J Clin Oncol       Date:  2015-05-16       Impact factor: 3.402

4.  Rising incidence of renal cell carcinoma in Ireland.

Authors:  Opeyemi A Falebita; Silvia Mancini; Eamonn Kiely; Harry Comber
Journal:  Int Urol Nephrol       Date:  2008-06-20       Impact factor: 2.370

5.  Risk factors for renal cell cancer in a Japanese population.

Authors:  Masakazu Washio; Mitsuru Mori
Journal:  Clin Med Oncol       Date:  2009-06-15

6.  Wide range and variation in minimally invasive surgery for renal malignancy in Japan: a population-based analysis.

Authors:  Toru Sugihara; Hideo Yasunaga; Hiromasa Horiguchi; Nobuo Tsuru; Tetsuya Fujimura; Hiroaki Nishimatsu; Haruki Kume; Kazuhiko Ohe; Shinya Matsuda; Kiyohide Fushimi; Yukio Homma
Journal:  Int J Clin Oncol       Date:  2012-11-23       Impact factor: 3.402

7.  Clinico-pathological analysis of renal cell carcinoma demonstrates decreasing tumour grade over a 17-year period.

Authors:  Gregory J Nason; Barry B McGuire; Michael E Kelly; Theodore M Murphy; Aisling T Looney; Damien P Byrne; David W Mulvin; David J Galvin; David M Quinlan; Gerald M Lennon
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

8.  Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature.

Authors:  Kosuke Ueda; Shigetaka Suekane; Katsuaki Chikui; Makoto Nakiri; Fukuko Moriya; Tokumasa Hayashi; Jiro Miyajima; Kei Matsuoka
Journal:  Mol Clin Oncol       Date:  2012-08-03

9.  Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1.

Authors:  Taiji Tsukamoto; Nobuo Shinohara; Norihiko Tsuchiya; Yasuo Hamamoto; Masayuki Maruoka; Hiroyuki Fujimoto; Masashi Niwakawa; Hirotsugu Uemura; Michiyuki Usami; Akito Terai; Hiro-omi Kanayama; Yoshiteru Sumiyoshi; Masatoshi Eto; Hideyuki Akaza
Journal:  Jpn J Clin Oncol       Date:  2010-10-21       Impact factor: 3.019

10.  Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial.

Authors:  Takeshi Ueda; Hirotsugu Uemura; Yoshihiko Tomita; Taiji Tsukamoto; Hiroomi Kanayama; Nobuo Shinohara; Jamal Tarazi; Connie Chen; Sinil Kim; Seiichiro Ozono; Seiji Naito; Hideyuki Akaza
Journal:  Jpn J Clin Oncol       Date:  2013-04-28       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.